Member Info for Dunk_Biscuit

I guess all the acquisitions made the whole accounting process highly complex and problematical . So I'll forgive Neo 🙂 especially as gold and uranium have gone up so much in the interim period ! Neo needs regulatory approval and before that is nailed down it's all a bit hit and miss it would seem . Not for the faint hearted 💔

My prediction is that it will result in a big deal 👍 There will be so many trying to muscle in on the amazing result of the last RNS 😀 Who wouldn't want to invest ?? Watch this space ! How quickly it will happen is difficult to predict 🤔 I will buy a packet of Garibaldi biscuits ( to celebrate ) if a deal happens 😉

FOMO Friday has arrived....this is a possible cure for a very aggressive form of lukemia ....keep the faith 🙌

It's happening right here , right now !

Those that are attending the summit will be wanting to buy shares in Hemo , there will be lots of discussions over the weekend and coming week . 😀

I think the summit is the catalyst...good timing ! DYOR. etc ..

Hemo will be the talk of New York and Washington....and it all kicks off today !

There will be lots of excitement at the summit 😀 lots of thinking over the weekend 😀

The summit in USA will provide more than enough momentum 👍 I wouldn't worry about that !

Hemo is now a sitting duck for a takeover. IMHO !

DYOR and good luck 👍

Hemo will be the talk of the summit ! Watch this space !

Once news sinks in over the pond expect lots of buying !

Sorry ...no extra cash needed ! Especially if a deal/ deals happen before the end of the year .

To sum up the interview...

1/ No cash needed for the foreseeable future

2/ Multiple applications for P140 across all autoimmune diseases (around 50 in total) both in diagnosis and treatment.

3/ Big market of 400 million patients, 100 billion total market for treatment and 10 billion total market for diagnosis across the WHOLE autoimmune space.

4/ The possibility of bringing sufferers from autoimmune disease into remission ❤️ as P140 regulates and brings back into balance any autoimmune irregularities (for a specific category of "sub-group M " patient .)

4/ Lots of interest from Big Pharma.

5/ A deal or deals expected in the next few months .

6/ Company valuation ? This is only the start !

7/ A unique , alternative treatment for autoimmune diseases which is safe and better than existing treatments .

Good luck ; exciting times ahead and a possible market leader in the treatment of all autoimmune diseases !! 👍 DYOR etc., etc..

Great interview, this is just the start 👍 👌 🙌

The autoimmune diagnostic market is currently worth around $6 billion and rising 👌

https://www.towardshealthcare.com/insights/autoimmune-disease-diagnostics-market-sizing

Anyone showing signs of any autoimmune disease (about 50 in total) will be able to have a test to see if they are "type m" just think of the population involved . 🤔 Massive market 👌 It makes the whole prospect of a deal very likely and very soon . It provides a quick way to market and revenues .

You forget the diagnostic side of the business for the 'type m' group . That market is huge and can be rolled out quickly . It will provide a much quicker income stream.

There's a HUGE diagnostic market here for the "type M" sub-group . That alone will underscore the value of IMM ......all other drug development will be a bonus 👌 That's what makes this investment a safe bet in my view ! DYOR etc. etc .

A subdued market is when you have ample opportunity to lower the sp (for no apparent reason ) ahead of anticipated market activity....what might that be ? Errr ASX 200 . There has already been a steady increase in the sp , since the ridiculously exaggerated slump in July , in anticipation of ASX 200 . Watch this space ! DYOR !!

Well you certainly haven't been a market maker for 40 years ! 🤣

It's not just supply and demand my friend. Nothing delusional going on here I can assure you !